APA

Kraiselburd E. N., Lavergne J. A., Woodall J. P., Kessler M. J., Meier G., Chiriboga J., Moore C. G., Sather G. E., Pomales A., Maldonado E. & Rivera R. (19811118). Lack of greater seroconversion of rhesus monkeys after subcutaneous inoculation of dengue type 2 live-virus vaccine combined with infection-enhancing antibodies. : Infection and immunity.

Chicago

Kraiselburd E N, Lavergne J A, Woodall J P, Kessler M J, Meier G, Chiriboga J, Moore C G, Sather G E, Pomales A, Maldonado E and Rivera R. 19811118. Lack of greater seroconversion of rhesus monkeys after subcutaneous inoculation of dengue type 2 live-virus vaccine combined with infection-enhancing antibodies. : Infection and immunity.

Harvard

Kraiselburd E. N., Lavergne J. A., Woodall J. P., Kessler M. J., Meier G., Chiriboga J., Moore C. G., Sather G. E., Pomales A., Maldonado E. and Rivera R. (19811118). Lack of greater seroconversion of rhesus monkeys after subcutaneous inoculation of dengue type 2 live-virus vaccine combined with infection-enhancing antibodies. : Infection and immunity.

MLA

Kraiselburd E N, Lavergne J A, Woodall J P, Kessler M J, Meier G, Chiriboga J, Moore C G, Sather G E, Pomales A, Maldonado E and Rivera R. Lack of greater seroconversion of rhesus monkeys after subcutaneous inoculation of dengue type 2 live-virus vaccine combined with infection-enhancing antibodies. : Infection and immunity. 19811118.